ÌÇÐÄTV¹ÙÍø

Michelle Le Beau, PhD, is the Arthur and Marian Edelstein professor emerita of medicine, section of hematology/oncology; director emerita of the University of Chicago Medicine Comprehensive Cancer Center, an NCI-designated comprehensive cancer center; and director emerita of the cancer cytogenetics laboratory at the University of Chicago. She is board-certified in clinical cytogenetics by the ÌÇÐÄTV¹ÙÍø Board of Medical Genetics and Genomics. Dr. Le Beau is a past member of the Board of Scientific Advisors of the National Cancer Institute, the past president of the Association of ÌÇÐÄTV¹ÙÍø Cancer Institutes, and a former member of the board of directors for the ÌÇÐÄTV¹ÙÍø Association for Cancer Research, the executive committee of the ÌÇÐÄTV¹ÙÍø Society of Hematology, the board of directors for the Leukemia and Lymphoma Society, and the National Cancer Policy Forum of the National Academy of Medicine. Dr. Le Beau has served on the ÌÇÐÄTV¹ÙÍø Cancer Society Board of Directors since 2019.